nsclc - Robuta Search

https://iris.unime.it/handle/11570/1912772 Folate pathway implications in advanced Non Small Cell Lung Cancer (NSCLC): impact of thymidylate... small cell lung cancer folate pathway implications https://www.hswt.de/forschung/forschungsprofil/publikationen/detail/improved-egfr-mutation-detection-using-combined-exosomal-rna-and-circulating-tumor-dna-in-nsclc-patient-plasma Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC... improved egfr mutation detection using https://www.clinicaltrialsarena.com/analyst-comment/enhertu-her2-targeting-treatment-nsclc/ Enhertu set to become the first HER2-targeting treatment for NSCLC May 29, 2023 - GlobalData predicts Enhertu to monopolise the niche of HER2-directed therapies for non-small cell lung cancer (NSCLC). set to the first treatment for become targeting https://www.oncologypipeline.com/apexonco/taxonomy/term/82 Lung cancer - NSCLC | ApexOnco - Clinical Trials news and analysis news and analysis lung cancer clinical trials nsclc https://go2.org/blog/fda-approves-new-combination-therapy-for-people-with-advanced-egfr-nsclc FDA Approves New Combination Therapy for People with Advanced EGFR+ NSCLC combination therapy for people fda approves new https://www.cancernetwork.com/view/motivating-treatment-persistence-in-egfr-mutated-nsclc Motivating Treatment Persistence in EGFR-Mutated NSCLC | CancerNetwork May 15, 2026 - In this segment, Dr. Alexander Spira and Dr. Natalie Vokes discuss how to effectively counsel patients on completing the full course of adjuvant therapy in... motivating treatment persistence egfr mutated https://stage.cancerimagingarchive.net/tcia-downloads/nsclc-radiomics-da-other/nsclc-radiomics-lung1-clinical-version3-oct-2019/ NSCLC-Radiomics-Lung1.clinical-version3-Oct-2019 - The Cancer Imaging Archive (TCIA) Apr 1, 2024 - NSCLC-Radiomics-Lung1.clinical-version3-Oct-2019 nsclc clinical oct cancer imaging https://www.hmpgloballearningnetwork.com/site/onc/videos/tumor-treating-fields-plus-standard-care-improved-overall-survival-among-patients Tumor Treating Fields for NSCLC Ticiana Leal, MD explains how tumor treating fields improved the overall survival among patients with non-small cell lung cancer. tumor treating fields nsclc https://ricerca.univaq.it/handle/11697/141028 Immune-related adverse events correlate with clinical outcomes in NSCLC patients treated with... adverse events clinical outcomes immune related correlate https://www.medicalindependent.ie/clinical-news/potential-major-changes-in-first-line-nsclc-treatment-with-targetable-tumour-cell-mutations/ Potential major changes in first-line NSCLC treatment with targetable tumour cell mutations -... Jan 30, 2024 - More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumour cells... first line potential major changes nsclc https://publires.unicatt.it/en/publications/type-of-lymphadenectomy-does-not-influence-survival-in-pia-nsclc-/ Type of lymphadenectomy does not influence survival in pIa NSCLC patients who underwent VATS... does not type influence survival pia https://air.unipr.it/handle/11381/2294720 5-benzylidene-hydantoin UPR 1024 acts as EGFR inhibitor and induces DNA damage in A549 NSCLC cell... dna damage upr acts egfr inhibitor https://www.ilcn.org/dr-jamie-e-chaft-discusses-emerging-data-on-induction-immunotherapy-for-nsclc/ Dr. Jamie E. Chaft Discusses Emerging Data on Induction Immunotherapy for NSCLC - ILCN.org... Dec 27, 2021 - Posted: March 1, 2019 In the following interview, Jamie E. Chaft, MD, a medical oncologist at the Memorial Sloan Kettering Cancer Center, discusses new data on... dr jamie chaft discusses emerging https://academy.astro.org/content/oligometastatic-nsclc-current-evidence-and-future-directions Oligometastatic NSCLC: Current Evidence and Future Directions | ASTRO current evidence future directions nsclc astro https://visualping.io/pages/docerampem-in-nsclc-clinical-trial-alerts-4964592 DoceRamPem in NSCLC Clinical Trial: Get alerts for the latest updates - Visualping See the latest updates to DoceRamPem in NSCLC Clinical Trial. Subscribe for free to get alerts when changes are detected to DoceRamPem in NSCLC Clinical Trial. for the latest clinical trial get alerts nsclc updates https://pharmadispatch.com/news/immutep-reaches-enrolment-target-for-insight-003-trial-in-first- Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC - BioPharmaDispatch Australian clinical-stage biotechnology company Immutep (ASX:IMM) has announced that the investigator-initiated INSIGHT-003 trial has reached its enrolment... first line immutep enrolment target insight https://adisinsight.springer.com/trials/700246912?error=cookies_not_supported&code=ea2aa400-993d-46bb-b38d-bf23866bb302 First Line Treatment of Elderly Patients With Advanced or Metastatic NSCLC With Docetaxel and... The investigators propose to study the efficacy and safety of the combination of Docetaxel plus Bevacizumab in a Phase II trial of elderly subjects with first line elderly patients treatment advanced metastatic https://www.esmo.org/meeting-calendar/esmo-congress-2024/industry-sponsored-satellite-symposia/non-metastatic-nsclc-and-other-thoracic-malignancies/treatment-modalities-in-early-stage-nsclc Treatment Modalities in Early-Stage NSCLC | ESMO treatment modalities early stage nsclc esmo https://www.qiagen.com/us/clp/nsclc NSCLC nsclc https://oncodaily.com/tag/stage-iii-nsclc Read News and Stories about stage III NSCLC - Oncodaily Here you can Find updates on "stage III NSCLC". news and stories read stage iii nsclc https://www.mednet.nl/podcast/podcast-egfr-ex20ins-gemuteerd-nsclc-in-de-dagelijkse-klinische-praktijk/ Podcast: EGFR ex20ins gemuteerd NSCLC in de dagelijkse klinische praktijk | MedNet Apr 21, 2026 - Podcastserie over EGFR ex20ins gemuteerd NSCLC. Krijg een overzicht van mogelijke behandelmethoden en het studielandschap rond deze specifieke mutatie. podcast egfr nsclc de dagelijkse https://www.medicaldevice-network.com/news/amgen-biomarker-assist-nsclc/ Amgen unveils Biomarker Assist programme for NSCLC patients Mar 13, 2023 - Amgen has introduced a programme called Biomarker Assist to allow more patients with metastatic NSCLC to access biomarker testing. amgen biomarker assist programme nsclc https://medical-data-models.org/17655?lang=sv Prevention and Treatment of Skin, Hair and Nail Reactions, Tarceva in NSCLC patients who have... Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind,... prevention and treatment skin hair nail reactions https://www.fsps.muni.cz/en/research/edicni-a-publikacni-cinnost/841964 Erlotinib (Tarceva) in patients with non-small-cell lung cancer (NSCLC)): results on 394 patients... in patients small cell lung cancer tarceva non https://ascopost.com/videos/iaslc-wclc-2025/concurrent-and-consolidation-durvalumab-for-unresectable-stage-iii-nsclc/ Concurrent and Consolidation Durvalumab for Unresectable Stage III NSCLC - The ASCO Post concurrent consolidation stage iii nsclc https://www.jcancer.org/v11p1606.htm Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? Pleurodesis and Immunotherapy in NSCLC; Medical Thoracoscopy or VATS? immunotherapy nsclc medical thoracoscopy vats https://www.clinrol.com/study/509 A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) | Clinrol Phase 1a/1b study of NVL-330 to evaluate safety, tolerability, and antitumor activity in advanced/metastatic HER2-altered NSCLC. a study in patients nvl advanced metastatic https://ecancer.org/en/video/8274-nivolumab-plus-ipilimumab-combination-offers-chemotherapy-free-option-for-advanced-nsclc Nivolumab plus ipilimumab combination offers chemotherapy-free option for advanced NSCLC - ecancer Prof Solange Peters presents data during a press conference at the 2019 ESMO congress from the CheckMate-227 trial. This was a trial looking at the two combination offers free option for advanced plus chemotherapy https://pubmed.ncbi.nlm.nih.gov/38149055/ Case report: SAF-189s is a potent inhibitor in a lorlatinib-resistant NSCLC patient with acquired... Acquired anaplastic lymphoma kinase (ALK) mutation is the major resistant mechanism to ALK tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer... case report saf potent inhibitor lorlatinib https://research.uni-luebeck.de/en/publications/stereotactic-body-radiation-therapy-sbrt-for-recurrent-non-small-/ Stereotactic Body Radiation Therapy (SBRT) for Recurrent Non-small Cell Lung Cancer (NSCLC) -... radiation therapy small cell lung cancer stereotactic body https://bioengineer.org/mettl16-links-ferroptosis-to-nsclc-tki-resistance/ METTL16 Links Ferroptosis to NSCLC TKI Resistance Aug 18, 2025 - In the relentless battle against non-small-cell lung cancer (NSCLC), a new molecular revelation is shedding light on the troubling phenomenon of resistance to... links ferroptosis nsclc tki resistance https://ctv.veeva.com/study/a-study-to-evaluate-safety-pk-and-efficacy-of-hs-10296-in-patients-with-nsclc?comeFrom=%7B%22type%22%3A%22site%22%2C%22slug%22%3A%22pacific-cancer-medical-center-anaheim-ca%22%7D A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC This is a Phase 1/2, open-label, multicenter study of HS-10296 with dose escalation, dose expansion and extension cohorts in locally advanced or metastatic... a study in patients evaluate safety pk https://www.research.va.gov/about/funded_research/proj-details-FY2019.cfm?pid=642345 I01CX002007-01 - Induction of Senescence using Dexamethasone to re-sensitize NSCLC to anti-PD1... induction senescence using dexamethasone nsclc https://www.canceropole-est.org/la-recherche-au-sein-du-canceropole-est/annuaires/publications-scientifiques/detail/?id=39950 Use of cancer vaccine after immunotherapy failure: a promising strategy for advanced NSCLC patients... cancer vaccine for advanced use immunotherapy failure https://medically.roche.com/ca/en/oncology/diseases/materials/princeps-data-point-to-feasibility-of-neoadjuvant-atezo.html PRINCEPS data point to feasibility of neoadjuvant atezolizumab in NSCLC data point princeps feasibility nsclc https://hub.tmu.edu.tw/en/publications/migration-and-invasion-of-nsclc-suppressed-by-the-downregulation-/fingerprints/ Migration and invasion of NSCLC suppressed by the downregulation of Src/focal adhesion kinase using... migration invasion nsclc suppressed src https://r10.risteys.finngen.fi/endpoints/HLP_C3_NSCLC_SQUAM Risteys FinnGen R10 - HLP_C3_NSCLC_SQUAM risteys hlp nsclc https://blackdoctor.com/living-with-nsclc-6-treatment-options-to-consider/ Living with NSCLC? 6 Treatment Options to Consider - BlackDoctor - Where Culture Meets Care Mar 6, 2026 - A diagnosis of non-small cell lung cancer (NSCLC) can feel overwhelming, but there are many effective treatment options available today. Whether you are newly living with treatment options nsclc consider blackdoctor https://lungcancer.net/forums/nsclc-diagnosis NSCLC Diagnosis | LungCancer.net nsclc diagnosis lungcancer https://www.texasoncology.com/clinical-trials/24110-Ph2-umbrella-study-with-rolling-arms-of-pembro-in-treatment-with-NSCLC-MK-3475-01E- Ph2 umbrella study with rolling arms of pembro in treatment with NSCLC (MK-3475-01E) | Clinical... Learn more about Phase II Clinical Trial for Lung Cancer at Texas Oncology. study with in treatment umbrella rolling arms https://iris.uniupo.it/handle/11579/159497 Prognostic effect of body mass index in patients with advanced NSCLC treated with... body mass index advanced nsclc effect patients treated https://avesis.gazi.edu.tr/yayin/8d15492d-7d7e-4faf-8a74-a961349b5804/risk-factors-of-radiation-pneumonitis-in-patients-with-nsclc-treated-with-concomitant-chemoradiotherapy-are-we-underestimating-diabetes-turkish-oncology-group-tog-lung-cancer-study-group Risk factors of radiation pneumonitis in patients with NSCLC treated with concomitant... risk factors in patients radiation pneumonitis nsclc https://sciencedatabase.strategian.com/?p=6401 O2(-) and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC... Nov 26, 2025 - Pharmacological ascorbate has been proposed as a potential anti-cancer agent when combined with radiation and chemotherapy. mediated disruption fe metabolism causes https://techyleak.com/innovative-breakthroughs-in-nsclc-treatment/ Innovative Breakthroughs in NSCLC Treatment - Techy Leak Dec 5, 2023 - "Discover the latest innovative breakthroughs in non-small cell lung cancer (NSCLC) treatment, including cutting-edge therapies and advancements in... innovative breakthroughs nsclc treatment techy leak https://www.bioworld.com/articles/712403-detailed-data-affirm-ivonescimab-tops-keytruda-in-nsclc-trial?v=preview Detailed data affirm ivonescimab tops Keytruda in NSCLC trial | BioWorld More than three months ago, investors first learned that ivonescimab, a PD-1/VEGF-targeting bispecific antibody from Summit Therapeutics and Akeso... detailed data affirm tops keytruda https://doctorlib.org/surgery/%D1%81hest/75.html Adjuvant and Neoadjuvant Radiotherapy in NSCLC - Adult Chest Surgery Adjuvant and Neoadjuvant Radiotherapy in NSCLC - Adult Chest Surgery - The book describes current techniques and surgical principles for the most common... adjuvant and neoadjuvant adult chest surgery radiotherapy nsclc https://biotechhunter.com/trials/NCT06396065 NCT06396065 - Phase III Study of AK112 for NSCLC Patients | Biotech Hunter | Biotech Hunter View clinical trial NCT06396065 details phase iii study nsclc patients biotech https://www.fredhutch.org/en/diseases/lung-cancer/facts-resources.html Lung Cancer Facts from Fred Hutch: NSCLC & SCLC Explained - Fred Hutch Get the facts on lung cancer, from differences between types to early signs to treatment breakthroughs. Fred Hutch is here with expert care and support. lung cancer facts fred hutch nsclc explained https://research-repository.uwa.edu.au/en/publications/sunvozertinib-for-nsclc-patients-with-egfr-exon-20-insertion-muta/ Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of... preliminary analysis nsclc patients egfr exon https://connect.uclahealth.org/dom/2025/10/24/osimertinib-plus-savolitinib-in-patients-with-egfr-mutated-advanced-nsclc-with-met-alterations-after-first-line-osimertinib-clinical-outcomes-safety-and-biomarker-analysis-a-brief-report/ Osimertinib Plus Savolitinib in Patients With EGFR-Mutated Advanced NSCLC With MET Alterations... Le X, Baik C, Cho BC, Riess JW, Piotrowska Z, Johannes de Langen A, Goldberg SB, Goldman JW, Reguart N, [...] in patients advanced nsclc plus egfr mutated https://ar.iiarjournals.org/content/42/10/4805 Efficacy of Chemoimmunotherapy in NSCLC Patients With Brain Metastasis With or Without Prior Brain... Background/Aim: Many patients with advanced lung cancer develop brain metastasis (BM); however, few reports confirming the efficacy of immune checkpoint... brain metastasis efficacy nsclc patients without https://www.themednet.org/what-1l-treatment-would-you-use-for-a-patient-with-newly-diagnosed-lung-adenocarcinoma-whose-cancer-has-both-an-egfr-exon-19-deletion-and-mutation-in-the-extracellular-portion-of-erbb2-that-is-predicted-to-be-activating-s310f How would you treat a patient with newly diagnosed stage IV NSCLC who has an activating mutation in... Physician discussion: How would you treat a patient with newly diagnosed stage IV NSCLC who has an activating mutation in the ERBB2 extracellular domain and a... would you a patient newly diagnosed treat stage https://pure.fujita-hu.ac.jp/ja/publications/efficacy-of-immune-checkpoint-inhibitor-with-or-without-chemother/fingerprints/ Efficacy of Immune Checkpoint Inhibitor With or Without Chemotherapy for Nonsquamous NSCLC With... immune checkpoint efficacy inhibitor without chemotherapy https://www.medicalhalo.com/en/oncology/2160.html Where can I buy Rybrevant, a targeted therapy for lung cancer (NSCLC)? Are the side effects... targeted therapy lung cancer side effects buy nsclc https://www.oaepublish.com/articles/2394-4722.2025.136 Circulating tumor DNA (ctDNA) in early-stage NSCLC: a new frontier in precision oncology Recent advances in the management of early-stage non-small cell lung cancer (NSCLC), including perioperative immunotherapy and targeted treatments, have... early stage new frontier precision oncology tumor dna https://cran.r-project.org/web/packages/drMAIC/vignettes/drMAIC_intro.html Doubly Robust MAIC for HTA: A Complete Worked Example in Advanced NSCLC worked example advanced nsclc robust maic hta https://boris-portal.unibe.ch/entities/publication/640a0166-440e-4584-99d2-e180428cf086 Is there a clinical consequence of CTV omission in SBRT of NSCLC? clinical consequence ctv omission nsclc https://www.biospace.com/asuragen-ngs-system-streamlines-detection-of-nsclc-associated-dna-mutations-gene-fusions-and-rna-expression-targets-in-single-workflow Asuragen NGS System Streamlines Detection of NSCLC-associated DNA Mutations, Gene Fusions, and RNA... Jun 6, 2019 - The targeted NGS panel enables the detection of 135 RNA and 55 DNA variants associated with non-small cell lung cancer dna mutations ngs system streamlines detection https://www.aacr.org/blog/tag/nonsquamous-nsclc/ Nonsquamous NSCLC Archives - American Association for Cancer Research (AACR) american association cancer research nonsquamous nsclc archives https://www.healthday.com/healthpro-news/cancer/surgery-for-early-stage-nsclc-yields-similar-outcomes-in-octogenarians-younger-patients Lung Cancer Surgery Safe for Octogenarians With Early-Stage NSCLC Surgical treatment for early-stage non-small cell lung cancer is associated with similarly favorable safety and long-term outcomes for octogenarians and for... lung cancer surgery early stage safe nsclc https://flcube.com/?p=32523 Innovent Biologics' Aoyixin Wins NMPA Approval for First-line NSCLC Treatment - Insight, China's... Apr 27, 2025 - China-based Innovent Biologics, Inc. (HKG: 1801) announced that it has received another indication approval from the National Medical Products Administration... first line biologics wins nmpa approval https://scholars.uky.edu/es/publications/immunization-of-nsclc-patients-with-antigen-pulsed-immature-autol/ Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cells - dendritic cells immunization nsclc patients antigen https://www.journalonko.de/thorakale-tumoren/nsclc/nsclc-adjuvant-immunchemotherapie-verbessert-heilung NSCLC: Adjuvante Immunchemotherapie verbessert Heilung Der Einsatz systemischer Therapien kann das Operationsergebnis beim resektablen NSCLC langfristig sichern. Mehr dazu lesen Sie hier! nsclc heilung https://www.ispor.org/vih-articles/Volume-15--Issue-7/PMD88-Disparities-in-Access-to-EGFR-Mutation-Testing-in-Patients-With-Advanced-NSCLC-in-Germany-2011 PMD88 Disparities in Access to EGFR-Mutation Testing in Patients With Advanced NSCLC in Germany 2011 egfr mutation testing access to advanced nsclc disparities patients https://digitalcommons.providence.org/publications/4766/ "Effect of prior therapy on tumor mutational burden in NSCLC." by Sushma Jonna, Ari Vanderwalde et... Background: Higher tumor mutation burden (TMB) in advanced non-small cell lung cancer (NSCLC) is associated with superior outcomes with checkpoint inhibitor... effect prior therapy tumor burden https://www.10xgenomics.com/cn/datasets/nsclc-tumor-ig-enrichment-from-amplified-c-dna-1-standard-2-2-0 NSCLC tumor - Ig enrichment from amplified cDNA | 10x Genomics nsclc tumor ig enrichment amplified